Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Loo, H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 53 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Loo, H; Saiz-Ruiz, J; Silva, JACE; Ansseau, M; Herrington, R; Vaz-Serra, A; Dilling, H; De Risio, S
      Efficacy and safety of tianeptine in the treatment of depressive disordersin comparison with fluoxetine

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    2. Gut-Fayand, A; Dervaux, A; Olie, JP; Loo, H; Poirier, MF; Krebs, MO
      Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity

      PSYCHIATRY RESEARCH
    3. Ito, C; Morisset, S; Krebs, MO; Olie, JP; Loo, H; Poirier, MF; Lannfelt, L; Schwartz, JC; Arrang, JM
      Histamine H-2 receptor gene variants: lack of association with schizophrenia

      MOLECULAR PSYCHIATRY
    4. Duaux, E; Krebs, MO; Loo, H; Poirier, MF
      Genetic vulnerability to drug abuse

      EUROPEAN PSYCHIATRY
    5. Millet, B; Leclaire, M; Bourdel, MC; Loo, H; Tezcan, E; Kuloglu, M
      Comparison of sociodemographic, clinical and phenomenological characteristics of Turkish and French patients suffering from obsessive-compulsive disorder

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    6. Bayle, FJ; Bourdel, MC; Caci, H; Gorwood, P; Chignon, JM; Ades, J; Loo, H
      Factorial structure of the French translation of the Barratt impulsivity scale (BIS-10)

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    7. Galinowski, A; Castelnau, C; Spreux-Varoquaux, O; Bourdel, MC; Olie, JP; Loo, H; Poirier, MF
      Evolution of Plasma Homovanillic Acid (HVA) levels during treatment in schizo-affective disorder

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    8. Bayle, FJ; Llorca, PM; Olie, JP; Loo, H
      Anxiety and schizophrenia: review of research

      ANNALES MEDICO-PSYCHOLOGIQUES
    9. Loo, H
      Pierre Deniker, 1917-1998 - In memoriam

      NEUROPSYCHOPHARMACOLOGY
    10. Loo, H; Saiz-Ruiz, J; Silva, JACE; Ansseau, M; Herrington, R; Vaz-Serra, A; Dilling, H; de Risio, S
      Efficacy and safety of tianeptine in the treatment of depressive disordersin comparison with fluoxetine

      JOURNAL OF AFFECTIVE DISORDERS
    11. Darcourt, G; Durocher, A; Enjalbert, JM; Garrabe, J; Glikman, J; Lienhart, A; Paquet, B; Pazart, L; Auriacombe, M; Chevalier, JF; Coffinet, P; De Carvalho, W; Frigard, B; Henry, E; Lermuzeaux, C; Viel, E; Allilaire, JF; Aulas, JJ; Aumond-Veyre, D; Bernardet, R; Bouvard, M; Brudon, F; Brun, M; Caroli, F; Cartier, G; Chassagnon, H; Chebili, S; Colonna, L; Gay, MC; Gonthier, R; Huet, F; Koupernik, C; Lacore, V; Lafont, JP; Laurent, V; Laxenaire, MC; Legrain, S; Lepine, JP; Loo, H; Meignan, ML; Michel, F; Moritz, P; Ourabah, R; Pages, M; Pages, G; Paillere-Martinot, ML; Pascal, JC; Pedelevental, C; Peretti, CS; Rousset, H; Savet, JF; Stael, P; Terra, JL; Thierry, P; Tignol, J; Barrier, G; Decroix, G; Gallois, P; Glorion, B; Lachaussee, H; Laurent, D; Sado, P; Sargos, P; Thouvenin, D
      Indications and modalities for electroconvulsive therapy. January 1998

      SEMAINE DES HOPITAUX
    12. Vacheron, MN; Millet, B; Gauillard, J; Doubremelle, C; Bayle, FJ; Loo, H
      Current nosographic position and diagnosis difficulties of pseudo-obsessive compulsive schizophrenia: A study from three case report

      ANNALES MEDICO-PSYCHOLOGIQUES
    13. Laxenaire; Loo, H; Abdelfattah; Hache; Feline; Garrabe; Hardy
      Information in depressive disorders and suicidal behaviors - Discussion

      ANNALES MEDICO-PSYCHOLOGIQUES
    14. Loo, H
      Pierre Deniker (1917-1998) - Obituary

      ANNALES DE MEDECINE INTERNE
    15. DUAUX E; GORWOOD P; GRIFFON N; BOURDEL MC; SAUTEL F; SOKOLOFF P; SCHWARTZ JC; ADES J; LOO H; POIRIER MF
      HOMOZYGOSITY AT THE DOPAMINE D-3 RECEPTOR GENE IS ASSOCIATED WITH OPIATE DEPENDENCE

      Molecular psychiatry
    16. KREBS MO; SAUTEL F; BOURDEL MC; SOKOLOFF P; SCHWARTZ JC; OLIE JP; LOO H; POIRIER MF
      DOPAMINE D-3 RECEPTOR GENE VARIANTS AND SUBSTANCE-ABUSE IN SCHIZOPHRENIA

      Molecular psychiatry
    17. KREBS MO; GUILLIN O; SOKOLOFF P; BOURDEL MC; SCHWARTZ JC; OLIE JP; LOO H; POIRIER MF
      ASSOCIATION STUDY OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) POLYMORPHISM IN SCHIZOPHRENIA

      American journal of medical genetics
    18. Loo, H; Olie, JP
      In memory of Pierre Deniker (1917-1998)

      EVOLUTION PSYCHIATRIQUE
    19. SABA G; DUAUX E; LOO H
      PSYCHIATRIC COMORBIDITY AND RETINITIS-PIG MENTOSA - A CASE-REPORT

      Annales medico-psychologiques
    20. GALINOWSKI A; POIRIER MF; AYMARD N; LEYRIS A; BEAUVERIE P; BOURDEL MC; LOO H
      EVOLUTION OF PLASMA HOMOVANILLIC-ACID (HVA) IN CHRONIC-SCHIZOPHRENIC PATIENTS TREATED WITH HALOPERIDOL

      Acta psychiatrica Scandinavica
    21. DELVALLE FR; LOO H; ARCE MA; CLASON D; SANCHEZLUCERO M
      EFFECTS OF PREGRINDING AND EXTRUSION ON QUALITY OF CORN TORTILLA FLOUR

      Food science and technology international
    22. FAVRE JD; GUELFISOZZI C; DELALLEAU B; LOO H
      TIANEPTINE AND ALCOHOL DEPENDENCE

      European neuropsychopharmacology
    23. KREBS MO; SAUTEL F; BOURDEL MC; SOKOLOFF P; SCHWARTZ JC; OLIE JP; LOO H; POIRIER MF
      DOPAMINE D3 RECEPTOR GENE VARIANTS AND PHARMACOSENSITIVE SCHIZOPHRENIC-PATIENTS

      American journal of medical genetics
    24. LOO H; POIRIERLITTRE MF; THERON M; REIN W; FLEUROT O
      AMISULPRIDE VERSUS PLACEBO IN THE MEDIUM-TERM TREATMENT OF THE NEGATIVE SYMPTOMS OF SCHIZOPHRENIA

      British Journal of Psychiatry
    25. LOO H; BARROIS C
      IS THERE A SPECIFIC CLINICAL-PATTERNS IN SUBSTANCE-ABUSERS AT FIRST INCARCERATION - DISCUSSION

      Annales medico-psychologiques
    26. NACEF F; BAYLE FJ; OLIE JP; LOO H
      PHARMACOPSYCHOSIS AND THEIR MEDICAL CONSE QUENCES

      Annales medico-psychologiques
    27. LOO P; LAXENAIRE M; KOUPERNIK C; FELINE A; SIZARET; BAZOT; LOO H
      PHARMACOPSYCHOSIS AND THEIR MEDICAL CONSE QUENCES - DISCUSSION

      Annales medico-psychologiques
    28. LOO H; OLIE JP; LAXENAIRE M; BAZOT
      CUTANEOUS EFFECTS OF LITHIUM - REVIEW OF THE LITERATURE AND A CASE-REPORT - DISCUSSION

      Annales medico-psychologiques
    29. LOO H; OLIE JP; POIRIER MF; AMADO I
      PSYCHOTROPIC-DRUGS AND BEHAVIOR

      Bulletin de l'Academie nationale de medecine
    30. LEVYSOUSSAN P; BERNEMAN A; POIRIER MF; GALINOWSKI A; LOO H; OLIE JP; AVRAMEAS S
      DIFFERENCES IN THE NATURAL AUTOANTIBODY PATTERNS OF PATIENTS WITH SCHIZOPHRENIA AND NORMAL INDIVIDUALS

      Journal of psychiatry & neuroscience
    31. MONTGOMERY SA; BAKISH D; BULLER R; GJERRIS A; KATSCHNIG H; LECRUBIER Y; LEPINE JP; MAURI M; SATORIUS N; CAMERON A; CASSANO G; COSTAESILVA J; DENBOER JA; FREEMAN C; VONKNORRING L; LOO H; NUTT D; ROSENBERG R
      ECNP POSITION PAPER ON SOCIAL PHOBIA - PROCEEDINGS FROM AN ECNP WORKSHOP IN JERUSALEM, OCTOBER 1994

      European neuropsychopharmacology
    32. CASSANO GB; HEINZE G; LOO H; MENDLEWICZ J; DESOUSA MP
      A DOUBLE-BLIND COMPARISON OF TIANEPTINE, IMIPRAMINE AND PLACEBO IN THE TREATMENT OF MAJOR DEPRESSIVE EPISODES

      European psychiatry
    33. VANELLE JM; BROCHIER T; BAYLE FJ; LOO H
      ATYPICAL NEUROLEPTICS - THEIR CONTRIBUTION TO THE REHABILITATION OF SCHIZOPHRENIC-PATIENTS

      European psychiatry
    34. BOUDEN A; KREBS MO; LOO H; OLIE JP
      MUNCHHAUSEN SYNDROME BY PROXY - A CHALLEN GE FOR MEDICINE

      La Presse medicale
    35. KREBS MO; BOUDEN A; LOO H; OLIE JP
      MUNCHHAUSEN SYNDROME BY PROXY IN ADULTS - A CASE BETWEEN WIFE AND HUSBAND

      La Presse medicale
    36. LAQUEILLE X; BAYLE FJ; SPADONE C; JALFRE V; LOO H
      TREATMENT OF DEPRESSIVE SYNDROMES IN DETOXIFIED DRUG-ADDICTS - USE OFMETHADONE

      Biomedicine & pharmacotherapy
    37. LOO H; LAQUEILLE X; REMI P; BAYLE F; OLIE JP
      METHADONE THERAPY FOR HEROIN USERS - VALU E, LIMITATIONS AND USE IN FRANCE

      La Semaine des hopitaux de Paris
    38. LONGEVIALLE R; AMADO I; KREBS MO; BOURDEL MC; GALINOWSKI A; POIRIER MF; LOO H; OLIE JP
      VISUOSPATIAL CONTEXT EFFECTS ON MEMORY PROCESSES IN SCHIZOPHRENIA

      International journal of psychology
    39. AMADO I; DENHIERE G; BOURDEL MC; POIRIER MF; OLIE JP; LOO H
      RECOGNITION MEMORY AND SCHIZOPHRENIA

      International journal of psychology
    40. BERNEMAN A; LEVYSOUSSAN P; LOO H; AVRAMEAS S
      DIFFERENCES IN THE NATURAL AUTOANTIBODY PATTERNS OF SCHIZOPHRENIC-PATIENTS AND NORMAL INDIVIDUALS

      Immunology
    41. GRANGER B; GARABEDIAN BVD; POIRIERLITTRE MF; GALINOWSKI A; LOO H
      REFUTATION OF THE HYPOTHESIS LINKING ANTI ACETYLCHOLINE RECEPTOR ANTIBODIES AND TARDIVE DYSKINESIAS

      Annales medico-psychologiques
    42. POIRIER MF; LOO H; GALINOWSKI A; BOURDEL MC; REMIBOUISSIERE P; PIKETTY ML; VANELLE JM
      SENSITIVE ASSAY OF THYROID-STIMULATING HORMONE IN DEPRESSED-PATIENTS

      Psychiatry research
    43. AMADOBOCCARA I; GOUGOULIS N; LITTRE MFP; GALINOWSKI A; LOO H
      EFFECTS OF ANTIDEPRESSANTS ON COGNITIVE FUNCTIONS - A REVIEW

      Neuroscience and biobehavioral reviews
    44. BAYLE FJ; CHASSOUX F; BROCHIER T; DEVAUX D; LOO H; CHODKIEWICZ J
      SURGICALLY REFRACTORY EPILEPTIC PATIENTS - LIFETIME EVALUATION AND FOLLOW-UP OF PSYCHIATRIC-DISORDERS

      Epilepsia
    45. LOO H; BROCHIER T
      LONG-TERM ANTIDEPRESSANTS USING

      Annales medico-psychologiques
    46. FLECK MPA; POIRIERLITTRE MF; GUELFI JD; BOURDEL MC; LOO H
      FACTORIAL STRUCTURE OF THE 17-ITEM HAMILTON DEPRESSION RATING-SCALE

      Acta psychiatrica Scandinavica
    47. VANELLE JM; LEIGH TH; LOO H; PRIEST RG
      RESISTANCE TO LITHIUM - WHAT ALTERNATIVES EXIST

      Human psychopharmacology
    48. VANELLE JM; LOO H; GALINOWSKI A; DECARVALHO W; BOURDEL MC; BROCHIER P; BOUVET O; BROCHIER T; OLIE JP
      MAINTENANCE ECT IN INTRACTABLE MANIC-DEPRESSIVE DISORDERS

      Convulsive therapy
    49. LEVYSOUSSAN P; BARBOUCHE R; POIRIER MF; GALINOWSKI A; LOO H; AVRAMEAS S
      A PRELIMINARY PROSPECTIVE-STUDY ON NATURAL AUTOANTIBODIES AND THE RESPONSE OF UNTREATED SCHIZOPHRENIC-PATIENTS TO NEUROLEPTICS

      Biological psychiatry
    50. ATTARLEVY D; BERGERIOUX L; FIDELLE G; BRILLAUD D; LOO H
      FAMILIAL PSYCHOSIS AND LINEAGE

      Annales medico-psychologiques
    51. GRASELA TH; FIEDLERKELLY IB; SALVADORI C; MAREY C; JOCHEMSEN R; LOO H
      PREDICTIVE PERFORMANCE OF POPULATION PHARMACOKINETIC PARAMETERS OF TIANEPTINE AS APPLIED TO PLASMA-CONCENTRATIONS FROM A POSTMARKETING STUDY

      European Journal of Clinical Pharmacology
    52. LOO H; BROCHIER T; POIRIER MF; OLIE JP
      REVIEW OF THE NEUROLEPTIC CHEMOTHERAPY DURING 40 YEARS

      Annales medico-psychologiques
    53. LOO H; LAQUEILLE X; REMI P; BAYLE F; OLIE JP
      SUBSTITUTIVE THERAPY OF HEROINE ADDICT BY METHADONE IN FRANCE - SIGNIFICANCE, LIMITATIONS AND PRACTICE IN FRANCE

      Bulletin de l'Academie nationale de medecine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/20 alle ore 03:10:51